Bradykinin and the pathogenesis of hereditary angioedema

World Allergy Organization Journal

Volumn 4, Issue 4, 2011, Pages 73-75

  Kaplan, Allen P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; BRADYKININ B2 RECEPTOR; COMPLEMENT COMPONENT C1S INHIBITOR; HEAT SHOCK PROTEIN 90; HIGH MOLECULAR WEIGHT KININOGEN; LOW MOLECULAR WEIGHT KININOGEN; PLASMA KALLIKREIN;

ANGIONEUROTIC EDEMA; ARTICLE; BLOOD VESSEL PERMEABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; SWELLING;

EID: 79954528195     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e318216b7b2     Document Type: Article

References (36)

1. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema. Am J Med. 1963;35:37-44.
2. Gigli I, Mason JW, Colman RW, Austen KF. Interaction of plasma kallikrein with the C1 inhibitor. J Immunol. 1970;104:574-581.
3. Donaldson VH, Rosen FS, Bing DH. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc Am Physicians. 1977;90: 174-183.
4. Strang CJ, Auerbach HS, Rosen FS. C1s-induced vascular permeability in C2-deficient guinea pigs. J Immunol. 1986;137:631-635. (Pubitemid 16045094)
5. Donaldson VH. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro. J Exp Med. 1968;127: 411-429.
6. Kaplan AP, Austen KF. A pre-albumin activator of prekallikrein. J Immunol. 1970;105:802-811.
7. Kaplan AP, Austen KF. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med. 1971;133:696-712.
8. Cochrane CG, Wuepper KD. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). J Exp Med. 1971;134:986-1004.
9. Mandle R Jr, Kaplan AP. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J Biol Chem. 1977; 252:6097-6104. (Pubitemid 8192564)
10. Wuepper KD, Miller DR, Lacombe MJ. Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest. 1975;56(6):1663-1672.
11. Colman RW, Bagdasarian A, Talamo RC, et al. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factordependent pathways. J Clin Invest. 1975;56(6):1650-1662.
12. Mandle RJ, Colman RW, Kaplan AP. Identification of and high-molecular-weight kininogen as a complex in human pl. Proc Natl Acad Sci. 1976;73:4179-4183.
13. Thompson RE, Mandle R Jr, Kaplan AP. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J Exp Med. 1978;147:488-499. (Pubitemid 8284120)
14. Thompson RE, Mandle R Jr, Kaplan AP. Studies of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci U S A. 1979;76:4862-4866 of binding. (Pubitemid 10229085)
15. Griffin JH. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci U S A. 1978;75:1998-2002. (Pubitemid 8335471)
16. Tankersley DL, Finlayson JS. Kinetics of activation and autoactivation of human factor XII. Biochemistry. 1984;23:273-279. (Pubitemid 14185168)
17. Silverberg M, Dunn JT, Garen L, Kaplan AP. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem. 1980;255:7281-7286. (Pubitemid 11245061)
18. Schreiber AD, Kaplan AP, Austen KF. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest. 1973;52:1402-1409.
19. Curd JG, Prograis LJ Jr, Cochrane CG. Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J Exp Med. 1980;152:742-747. (Pubitemid 10059504)
20. Fields T, Ghebrehiwet B, Kaplan AP. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol. 1983;72:54-60. (Pubitemid 13069361)
21. Strang CJ, Cholin S, Spragg J, Davis AE 3rd, Schneeberger EE, Donaldson VH, Rosen FS. Angioedema induced by a peptide derived from complement component C2. J Exp Med. 1988;168:1685-1698. (Pubitemid 19023256)
22. Smith M, Kerr M. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency. Immunology. 1985;56(3):561-570. (Pubitemid 15245012)
23. Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE 3rd. Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol. 1994;95:22-28. (Pubitemid 24207098)
24. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE 3rd. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest. 2002;109(8):1057-1063. (Pubitemid 34408580)
25. Nussberger J, Cugno M, Cicardi M, Agostoni A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol. 1999;104: 1321-1322. (Pubitemid 30004997)
26. Zahedi R, Bissler JJ, Davis AE 3rd, Andreadis C, Wisnieski JJ. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-Val substitution and functional analysis of the recombinant mutant protein. J Clin Invest. 1995;95:1299-1305.
27. Kaplan A, Ghebrehiwet B. Does C-2 kinin exist? J Allergy Clin Immunol. 2004;115:876.
28. Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010;363(6):513-522.
29. Cicardi M, Levy RJ, McNeil DL, Li HH, Sheffer AL, et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med. 2010;363:523-531.
30. Cicardi M, Banerji A, Bracho F, Malbran A, Rosenkranz B, et al. Icatibant, a new bradykinin receptor antogonist in hereditary angioedema. N Engl J Med. 2010;363:532-541.
31. Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 1983;71:1450-1456. (Pubitemid 13098935)
32. Joseph K, Tholanikunnel BG, Kaplan AP. Factor XII-independent cleavage of high molecular weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009;124:143-149.
33. Joseph K, Tholanikunnel BG, Kaplan AP. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci. 2002;99:896-900. (Pubitemid 34106607)
34. Joseph K, Tholanikunnel BG, Ghebrehiwet B, Kaplan AP. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb Haemost. 2004;91:61-70. (Pubitemid 38111221)
35. Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP. Factor XIIdependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb Haemost. 2001;85(1):119-124. (Pubitemid 32050953)
36. Joseph K, Ghebrehiwet B, Kaplan AP. Activation of the kinin-forming cascade on the surface of endothelial cells. Biol Chem. 2001;382:71-75.